Global Hepatitis B Vaccines Market Growth 2021-2026

  • receipt Report ID : 153668
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 138
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Hepatitis B Vaccines will have significant change from previous year. By the most conservative estimates of global Hepatitis B Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 973 million in 2019. Over the next five years the Hepatitis B Vaccines market will register a 1.8% CAGR in terms of revenue, the global market size will reach US$ 1046.9 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis B Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Yeast Derived

CHO Derived

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Children

Adult

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

GSK

NCPC

Merck

Bio Kangtai

Dynavax

Hissen

KM Biologics

LG Life Sciences

Serum Institute

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hepatitis B Vaccines Consumption 2016-2026

2.1.2 Hepatitis B Vaccines Consumption CAGR by Region

2.2 Hepatitis B Vaccines Segment by Type

2.2.1 Yeast Derived

2.2.2 CHO Derived

2.3 Hepatitis B Vaccines Sales by Type

2.3.1 Global Hepatitis B Vaccines Sales Market Share by Type (2016-2021)

2.3.2 Global Hepatitis B Vaccines Revenue and Market Share by Type (2016-2021)

2.3.3 Global Hepatitis B Vaccines Sale Price by Type (2016-2021)

2.4 Hepatitis B Vaccines Segment by Application

2.4.1 Children

2.4.2 Adult

2.5 Hepatitis B Vaccines Sales by Application

2.5.1 Global Hepatitis B Vaccines Sale Market Share by Application (2016-2021)

2.5.2 Global Hepatitis B Vaccines Revenue and Market Share by Application (2016-2021)

2.5.3 Global Hepatitis B Vaccines Sale Price by Application (2016-2021)

3 Global Hepatitis B Vaccines by Company

3.1 Global Hepatitis B Vaccines Sales Market Share by Company

3.1.1 Global Hepatitis B Vaccines Sales by Company (2019-2021)

3.1.2 Global Hepatitis B Vaccines Sales Market Share by Company (2019-2021)

3.2 Global Hepatitis B Vaccines Revenue Market Share by Company

3.2.1 Global Hepatitis B Vaccines Revenue by Company (2019-2021)

3.2.2 Global Hepatitis B Vaccines Revenue Market Share by Company (2019-2021)

3.3 Global Hepatitis B Vaccines Sale Price by Company

3.4 Global Manufacturers Hepatitis B Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Hepatitis B Vaccines Product Location Distribution

3.4.2 Players Hepatitis B Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Hepatitis B Vaccines by Region

4.1 Global Hepatitis B Vaccines by Region

4.1.1 Global Hepatitis B Vaccines Sales by Region

4.1.2 Global Hepatitis B Vaccines Revenue by Region

4.2 Americas Hepatitis B Vaccines Sales Growth

4.3 APAC Hepatitis B Vaccines Sales Growth

4.4 Europe Hepatitis B Vaccines Sales Growth

4.5 Middle East & Africa Hepatitis B Vaccines Sales Growth

5 Americas

5.1 Americas Hepatitis B Vaccines Sales by Country

5.1.1 Americas Hepatitis B Vaccines Sales by Country (2016-2021)

5.1.2 Americas Hepatitis B Vaccines Revenue by Country (2016-2021)

5.2 Americas Hepatitis B Vaccines Sales by Type

5.3 Americas Hepatitis B Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hepatitis B Vaccines Sales by Region

6.1.1 APAC Hepatitis B Vaccines Sales by Region (2016-2021)

6.1.2 APAC Hepatitis B Vaccines Revenue by Region (2016-2021)

6.2 APAC Hepatitis B Vaccines Sales by Type

6.3 APAC Hepatitis B Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Hepatitis B Vaccines by Country

7.1.1 Europe Hepatitis B Vaccines Sales by Country (2016-2021)

7.1.2 Europe Hepatitis B Vaccines Revenue by Country (2016-2021)

7.2 Europe Hepatitis B Vaccines Sales by Type

7.3 Europe Hepatitis B Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hepatitis B Vaccines by Country

8.1.1 Middle East & Africa Hepatitis B Vaccines Sales by Country (2016-2021)

8.1.2 Middle East & Africa Hepatitis B Vaccines Revenue by Country (2016-2021)

8.2 Middle East & Africa Hepatitis B Vaccines Sales by Type

8.3 Middle East & Africa Hepatitis B Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Hepatitis B Vaccines Distributors

10.3 Hepatitis B Vaccines Customer

11 Global Hepatitis B Vaccines Market Forecast

11.1 Global Hepatitis B Vaccines Forecast by Region

11.1.1 Global Hepatitis B Vaccines Forecast by Regions (2021-2026)

11.2.2 Global Hepatitis B Vaccines Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Hepatitis B Vaccines Forecast by Type

11.7 Global Hepatitis B Vaccines Forecast by Application

12 Key Players Analysis

12.1 GSK

12.1.1 GSK GSK Company Information

12.1.2 GSK Hepatitis B Vaccines Product Offered

12.1.3 GSK Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 GSK Main Business Overview

12.1.5 GSK Latest Developments

12.2 NCPC

12.2.1 NCPC Company Information

12.2.2 NCPC Hepatitis B Vaccines Product Offered

12.2.3 NCPC Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 NCPC Main Business Overview

12.2.5 NCPC Latest Developments

12.3 Merck

12.3.1 Merck Company Information

12.3.2 Merck Hepatitis B Vaccines Product Offered

12.3.3 Merck Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Merck Main Business Overview

12.3.5 Merck Latest Developments

12.4 Bio Kangtai

12.4.1 Bio Kangtai Company Information

12.4.2 Bio Kangtai Hepatitis B Vaccines Product Offered

12.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Bio Kangtai Main Business Overview

12.4.5 Bio Kangtai Latest Developments

12.5 Dynavax

12.5.1 Dynavax Company Information

12.5.2 Dynavax Hepatitis B Vaccines Product Offered

12.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Dynavax Main Business Overview

12.5.5 Dynavax Latest Developments

12.6 Hissen

12.6.1 Hissen Company Information

12.6.2 Hissen Hepatitis B Vaccines Product Offered

12.6.3 Hissen Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Hissen Main Business Overview

12.6.5 Hissen Latest Developments

12.7 KM Biologics

12.7.1 KM Biologics Company Information

12.7.2 KM Biologics Hepatitis B Vaccines Product Offered

12.7.3 KM Biologics Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 KM Biologics Main Business Overview

12.7.5 KM Biologics Latest Developments

12.8 LG Life Sciences

12.8.1 LG Life Sciences Company Information

12.8.2 LG Life Sciences Hepatitis B Vaccines Product Offered

12.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 LG Life Sciences Main Business Overview

12.8.5 LG Life Sciences Latest Developments

12.9 Serum Institute

12.9.1 Serum Institute Company Information

12.9.2 Serum Institute Hepatitis B Vaccines Product Offered

12.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Serum Institute Main Business Overview

12.9.5 Serum Institute Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Hepatitis B Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Yeast Derived

Table 3. Major Players of CHO Derived

Table 4. Global Hepatitis B Vaccines Sales by Type (2016-2021) & (M Doses)

Table 5. Global Hepatitis B Vaccines Sales Market Share by Type (2016-2021)

Table 6. Global Hepatitis B Vaccines Revenue by Type (2016-2021) & ($ million)

Table 7. Global Hepatitis B Vaccines Revenue Market Share by Type (2016-2021)

Table 8. Global Hepatitis B Vaccines Sale Price by Type (2016-2021)

Table 9. Global Hepatitis B Vaccines Sales by Application (2016-2021) & (M Doses)

Table 10. Global Hepatitis B Vaccines Sales Market Share by Application (2016-2021)

Table 11. Global Hepatitis B Vaccines Value by Application (2016-2021)

Table 12. Global Hepatitis B Vaccines Revenue Market Share by Application (2016-2021)

Table 13. Global Hepatitis B Vaccines Sale Price by Application (2016-2021)

Table 14. Global Hepatitis B Vaccines Sales by Company (2019-2021) & (M Doses)

Table 15. Global Hepatitis B Vaccines Sales Market Share by Company (2019-2021)

Table 16. Global Hepatitis B Vaccines Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Hepatitis B Vaccines Revenue Market Share by Company (2019-2021)

Table 18. Global Hepatitis B Vaccines Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Hepatitis B Vaccines Producing Area Distribution and Sales Area

Table 20. Players Hepatitis B Vaccines Products Offered

Table 21. Hepatitis B Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Hepatitis B Vaccines Sales by Region (2016-2021) (M Doses)

Table 25. Global Hepatitis B Vaccines Sales Market Share by Region (2016-2021)

Table 26. Global Hepatitis B Vaccines Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Hepatitis B Vaccines Revenue Market Share by Region (2016-2021)

Table 28. Americas Hepatitis B Vaccines Sales by Country (2016-2021) & (M Doses)

Table 29. Americas Hepatitis B Vaccines Sales Market Share by Country (2016-2021)

Table 30. Americas Hepatitis B Vaccines Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Hepatitis B Vaccines Revenue Market Share by Country (2016-2021)

Table 32. Americas Hepatitis B Vaccines Sales by Type (2016-2021) & (M Doses)

Table 33. Americas Hepatitis B Vaccines Sales Market Share by Type (2016-2021)

Table 34. Americas Hepatitis B Vaccines Sales by Application (2016-2021) & (M Doses)

Table 35. Americas Hepatitis B Vaccines Sales Market Share by Application (2016-2021)

Table 36. APAC Hepatitis B Vaccines Sales by Region (2016-2021) & (M Doses)

Table 37. APAC Hepatitis B Vaccines Sales Market Share by Region (2016-2021)

Table 38. APAC Hepatitis B Vaccines Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Hepatitis B Vaccines Revenue Market Share by Region (2016-2021)

Table 40. APAC Hepatitis B Vaccines Sales by Type (2016-2021) & (M Doses)

Table 41. APAC Hepatitis B Vaccines Sales Market Share by Type (2016-2021)

Table 42. APAC Hepatitis B Vaccines Sales by Application (2016-2021) & (M Doses)

Table 43. APAC Hepatitis B Vaccines Sales Market Share by Application (2016-2021)

Table 44. Europe Hepatitis B Vaccines Sales by Country (2016-2021) & (M Doses)

Table 45. Europe Hepatitis B Vaccines Sales Market Share by Country (2016-2021)

Table 46. Europe Hepatitis B Vaccines Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Hepatitis B Vaccines Revenue Market Share by Country (2016-2021)

Table 48. Europe Hepatitis B Vaccines Sales by Type (2016-2021) & (M Doses)

Table 49. Europe Hepatitis B Vaccines Sales Market Share by Type (2016-2021)

Table 50. Europe Hepatitis B Vaccines Sales by Application (2016-2021) & (M Doses)

Table 51. Europe Hepatitis B Vaccines Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Hepatitis B Vaccines Sales by Country (2016-2021) & (M Doses)

Table 53. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Hepatitis B Vaccines Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Hepatitis B Vaccines Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Hepatitis B Vaccines Sales by Type (2016-2021) & (M Doses)

Table 57. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Hepatitis B Vaccines Sales by Application (2016-2021) & (M Doses)

Table 59. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Application (2016-2021)

Table 60. Global Hepatitis B Vaccines Sales Forecast by Type (2021-2026) & (M Doses)

Table 61. Global Hepatitis B Vaccines Sales Market Share Forecast by Type (2021-2026)

Table 62. Global Hepatitis B Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 63. Global Hepatitis B Vaccines Revenue Market Share Forecast by Type (2021-2026)

Table 64. Global Hepatitis B Vaccines Sales Forecast by Application (2021-2026) & (M Doses)

Table 65. Global Hepatitis B Vaccines Sales Market Share Forecast by Application (2021-2026)

Table 66. Global Hepatitis B Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 67. Global Hepatitis B Vaccines Revenue Market Share Forecast by Application (2021-2026)

Table 68. GSK Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 69. GSK Hepatitis B Vaccines Product Offered

Table 70. GSK Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 71. GSK Main Business

Table 72. GSK Latest Developments

Table 73. NCPC Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 74. NCPC Hepatitis B Vaccines Product Offered

Table 75. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 76. NCPC Main Business

Table 77. NCPC Latest Developments

Table 78. Merck Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 79. Merck Hepatitis B Vaccines Product Offered

Table 80. Merck Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 81. Merck Main Business

Table 82. Merck Latest Developments

Table 83. Bio Kangtai Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 84. Bio Kangtai Hepatitis B Vaccines Product Offered

Table 85. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 86. Bio Kangtai Main Business

Table 87. Bio Kangtai Latest Developments

Table 88. Dynavax Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 89. Dynavax Hepatitis B Vaccines Product Offered

Table 90. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 91. Dynavax Main Business

Table 92. Dynavax Latest Developments

Table 93. Hissen Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. Hissen Hepatitis B Vaccines Product Offered

Table 95. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 96. Hissen Main Business

Table 97. Hissen Latest Developments

Table 98. KM Biologics Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. KM Biologics Hepatitis B Vaccines Product Offered

Table 100. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 101. KM Biologics Main Business

Table 102. KM Biologics Latest Developments

Table 103. LG Life Sciences Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. LG Life Sciences Hepatitis B Vaccines Product Offered

Table 105. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 106. LG Life Sciences Main Business

Table 107. LG Life Sciences Latest Developments

Table 108. Serum Institute Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. Serum Institute Hepatitis B Vaccines Product Offered

Table 110. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 111. Serum Institute Main Business

Table 112. Serum Institute Latest Developments

List of Figures

Figure 1. Picture of Hepatitis B Vaccines

Figure 2. Hepatitis B Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Hepatitis B Vaccines Sales Growth Rate 2016-2026 (M Doses)

Figure 7. Global Hepatitis B Vaccines Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Hepatitis B Vaccines Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Yeast Derived

Figure 10. Product Picture of CHO Derived

Figure 11. Global Hepatitis B Vaccines Sales Market Share by Type in 2020

Figure 12. Global Hepatitis B Vaccines Revenue Market Share by Type (2016-2021)

Figure 13. Hepatitis B Vaccines Consumed in Children

Figure 14. Global Hepatitis B Vaccines Market: Children (2016-2021) & (M Doses)

Figure 15. Hepatitis B Vaccines Consumed in Adult

Figure 16. Global Hepatitis B Vaccines Market: Adult (2016-2021) & (M Doses)

Figure 17. Global Hepatitis B Vaccines Sales Market Share by Application (2016-2021)

Figure 18. Global Hepatitis B Vaccines Revenue Market Share by Application in 2020

Figure 19. Global Hepatitis B Vaccines Revenue Market by Company in 2020 ($ Million)

Figure 20. Global Hepatitis B Vaccines Revenue Market Share by Company in 2020

Figure 21. Global Hepatitis B Vaccines Sales Market Share by Regions (2016-2021)

Figure 22. Global Hepatitis B Vaccines Revenue Market Share by Region in 2020

Figure 23. Americas Hepatitis B Vaccines Sales 2016-2021 (M Doses)

Figure 24. Americas Hepatitis B Vaccines Revenue 2016-2021 ($ Millions)

Figure 25. APAC Hepatitis B Vaccines Sales 2016-2021 (M Doses)

Figure 26. APAC Hepatitis B Vaccines Revenue 2016-2021 ($ Millions)

Figure 27. Europe Hepatitis B Vaccines Sales 2016-2021 (M Doses)

Figure 28. Europe Hepatitis B Vaccines Revenue 2016-2021 ($ Millions)

Figure 29. Middle East & Africa Hepatitis B Vaccines Sales 2016-2021 (M Doses)

Figure 30. Middle East & Africa Hepatitis B Vaccines Revenue 2016-2021 ($ Millions)

Figure 31. Americas Hepatitis B Vaccines Sales Market Share by Country in 2020

Figure 32. Americas Hepatitis B Vaccines Revenue Market Share by Country in 2020

Figure 33. Americas Hepatitis B Vaccines Sales Market Share by Type in 2020

Figure 34. Americas Hepatitis B Vaccines Sales Market Share by Application in 2020

Figure 35. United States Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 36. Canada Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 37. Mexico Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 38. Brazil Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 39. APAC Hepatitis B Vaccines Sales Market Share by Region in 2020

Figure 40. APAC Hepatitis B Vaccines Revenue Market Share by Regions in 2020

Figure 41. APAC Hepatitis B Vaccines Sales Market Share by Type in 2020

Figure 42. APAC Hepatitis B Vaccines Sales Market Share by Application in 2020

Figure 43. China Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 44. Japan Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 45. Korea Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 46. Southeast Asia Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 47. India Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 48. Australia Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 49. Europe Hepatitis B Vaccines Sales Market Share by Country in 2020

Figure 50. Europe Hepatitis B Vaccines Revenue Market Share by Country in 2020

Figure 51. Europe Hepatitis B Vaccines Sales Market Share by Type in 2020

Figure 52. Europe Hepatitis B Vaccines Sales Market Share by Application in 2020

Figure 53. Germany Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 54. France Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 55. UK Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 56. Italy Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 57. Russia Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 58. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Country in 2020

Figure 59. Middle East & Africa Hepatitis B Vaccines Revenue Market Share by Country in 2020

Figure 60. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Type in 2020

Figure 61. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Application in 2020

Figure 62. Egypt Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 63. South Africa Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 64. Israel Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 65. Turkey Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 66. GCC Country Hepatitis B Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles